apocell Home Contact Us

Biomarkers ahead.

Personalized medicine is the wave of the future, and ApoCell is at the forefront of discovering and analyzing biomarkers that will make this new treatment revolution possible. ApoCell possesses the technologies which allow biomarker analysis to be performed on tissues, blood, other biological fluids, and on enriched rare cells. Investigating rare cells of interest in whole blood can help avoid the need for invasive sampling like biopsies and may also reveal modifications in tumor cell phenotype. The analytes available for investigation are vast and range from simple enumeration of a specific phenotype and expression of phosphorylated receptor tyrosine kinases to mutational detection and analysis of genetic alteration on a rare cell population. ApoCell works closely with the client to identify the best suited targets and methods of detection.